Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Merck
US Army
Accenture
UBS
Fuji
Federal Trade Commission
Express Scripts
Harvard Business School

Generated: April 20, 2018

DrugPatentWatch Database Preview

DICYCLOMINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Dicyclomine Hydrochloride patents expire, and what generic alternatives are available?

Dicyclomine Hydrochloride is a drug marketed by Hikma Pharms, Lannett, Mylan, Pioneer Pharms, Sun Pharm Industries, Watson Labs, Luitpold Pharms Inc, Alpharma Us Pharms, Mikart, and West-ward Pharms Int. and is included in nineteen NDAs.

The generic ingredient in DICYCLOMINE HYDROCHLORIDE is dicyclomine hydrochloride. There are four drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the dicyclomine hydrochloride profile page.
Drug patent expirations by year for DICYCLOMINE HYDROCHLORIDE
Pharmacology for DICYCLOMINE HYDROCHLORIDE
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Medical Subject Heading (MeSH) Categories for DICYCLOMINE HYDROCHLORIDE
Synonyms for DICYCLOMINE HYDROCHLORIDE
(1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(diethylamino)ethyl ester, hydrochloride
(1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(diethylamino)ethyl ester, hydrochloride (1:1)
(2-(((1,1'-Bicyclohexyl)-1-ylcarbonyl)oxy)ethyl)diethylammonium chloride
(BICYCLOHEXYL)-1-CARBOXYLIC ACID, 2-(DIETHYLAMINO)ETHYL ESTER, HYDROCHLORIDE
[1,1-Bicyclohexyl]-1-carboxylic acid 2-(diethylamino)ethyl ester hydrochloride
[1,1'-Bicyclohexyl]-1-carboxylic acid, 2-(diethylamino)ethyl ester, hydrochloride (1:1)
[Bicyclohexyl]-1-carboxylic acid diethylaminoethyl ester
067D925
1-Cyclohexyl-cyclohexan-1-carbonsaeure-2-diaethylaminoaethylester hydrochlorid
1-Cyclohexyl-cyclohexan-1-carbonsaeure-2-diaethylaminoaethylester hydrochlorid [German]
2-(Diethylamino)ethyl (bicyclohexyl)-1-carboxylate hydrochloride
2-(Diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate hydrochloride
2-(Diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate hydrochloride; [1,1-Bicyclohexyl]-1-carboxylic acid 2-(diethylamino)ethyl ester hydrochloride
2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate;hydrochloride
2-(diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate hydrochloride
2-(diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate, chloride
2-Diethylaminoethyl bicyclohexyl-1-carboxylate hydrochloride
67-92-5
77-19-0 (Parent)
79988-11-7
AB1004835
AC1L9B0G
AI3-18105
AKOS015950777
Ametil
AN-23770
Antispas
Benacol
Bentyl
Bentyl (TN)
BENTYL PRESERVATIVE FREE
beta-Diethylaminoethyl 1-cyclohexylcyclohexanecarboxylate hydrochloride
beta-Diethylaminoethyl-1-cyclohexylcyclohexanecarboxylate hydrochloride
beta-Diethylaminoethyl-1-cyclohexylhexahydrobenzoate hydrochloride
Bis(cyclohexyl)carboxylic acid diethylaminoethyl ester hydrochloride
C19H35NO2.HCl
CCG-39149
CHEBI:4515
CHEMBL1200479
Cloridrato dell'estere beta-dietil aminoetilico dell'acido cicloesil-1-cicloesancarbossilico
CPD000058440
CQ903KQA31
D 7909
D00717
Dibent
Dicyclomine Hcl
Dicyclomine hydrochloride (JAN/USP)
Dicyclomine hydrochloride (preservative-free)
Dicyclomine hydrochloride [USAN]
Dicyclomine hydrochloride [USP]
Dicyclomine hydrochloride, >=99% (TLC), powder
Dicyclomine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Dicycloverin hydrochloride
Dicycloverine HCl
Dicycloverine hydrochloride
Dicycloverine hydrochloride, European Pharmacopoeia (EP) Reference Standard
DTXSID0058778
EINECS 200-671-1
EU-0100432
FT-0624744
HMS1568I17
HMS1920E22
Icramin
LP00432
LS-43730
LS-56641
MCULE-7810636561
MFCD00079158
MLS000028426
MLS001074064
MolPort-003-666-161
NC00504
NCGC00093853-01
NCGC00093853-02
NCGC00093853-03
NCGC00093853-04
NCGC00093853-05
NCGC00261117-01
NSC 404381
NSC-756727
NSC756727
Opera_ID_272
Pharmakon1600-01500240
Prestwick_891
REGID_for_CID_441344
SAM002554894
SBB058148
SCHEMBL41670
SMR000058440
Spasmoject
SPECTRUM1500240
SR-01000003056
SR-01000003056-2
ST51014989
Stannitol
Tox21_500432
UNII-CQ903KQA31

US Patents and Regulatory Information for DICYCLOMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride CAPSULE;ORAL 040204-001 Feb 28, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride TABLET;ORAL 085223-001 Jul 30, 1986 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride CAPSULE;ORAL 085082-001 Jun 19, 1986 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pioneer Pharms DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride CAPSULE;ORAL 089361-001 Jan 10, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Deloitte
AstraZeneca
Accenture
Colorcon
Argus Health
Fish and Richardson
Chubb
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.